Cordova, Teresita G.
HRN: 11-82-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/09/2022
09/16/2022
IVTT
500 Mg
Q8 H
Diabetic Foot Grade 2-3
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes